Navigation Links
HRP Stabilizing Diluent (Phosphate Buffered) from ScyTek Laboratories

ProductsHRP Stabilizing Diluent (Phosphate Buffered) from ScyTek Laboratories
Company ScyTek Laboratories
Item HRP Stabilizing Diluent (Phosphate Buffered)
Price $1,591.00
Description This product has been developed to significantly increase the shelf life of diluted peroxidase labeled proteins. Stability is increased at room temperature storage conditions in addition to 2-8 centigrade. This product is subjected to 0.45 micron filtration, and contains no mercury or azide. This formulation insures consistently high levels of activity for both the enzyme and the antibody following long-term storage at final-use dilution. HRP Stabilizer greatly improves the signal to noise ratios which increases the immunoassay sensitivity and offers cleaner assays. This product has been chemically engineered to increase conjugate stability providing the customer a longer shelf life, resistance to various shipping conditions & storage temperatures and improved day to day assay precision.

This product is recommended to be used in conjunction with ScyTek's proprietary Coating Stabilizer, Blocking Buffer (Super Block), Washing solution, TMB and Stopping Solution. All of the ELISA products are available in bulk quantities, including custom lot sizes up to 5000 liters. ScyTek Laboratories, Inc. specializes in custom manufacturing, vialing, labeling and packaging. Call today for a quote 800-729-8350.

Info ScyTek LaboratoriesScyTek Laboratories
205 South 600 West
Logan, UT 84321
Customer Service: (800) 729-8350
Fax Number: (435) 755-0015
Web Site: http://www.scytek.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Peroxidase, Horseradish, Conjugate-Stabilizing Solution from Calbiochem
2. Alk-Phos Stabilizing Diluent from ScyTek Laboratories
3. Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
4. Alk-Phos Stabilizing Diluent from ScyTek Laboratories
5. Conjugate Stabilizing Diluent HRP from Meridian Life Science, Inc.
6. HRP Stabilizing Diluent (Phosphate Buffered) without BSA from ScyTek Laboratories
7. HRP Stabilizing Diluent (MOPS Buffered) from ScyTek Laboratories
8. HRP Stabilizing Diluent (Phosphate Buffered) without BSA from ScyTek Laboratories
9. HRP Stabilizing Diluent (Phosphate Buffered) from ScyTek Laboratories
10. ELISA Antibody Diluent-Rabbit Polyclonal from AbD Serotec
11. HRP Monoclonal-Goat Diluent - 5X Concentrate from BioFX Laboratories, Inc.
Rabbit polyclonal to Yaf9 ( Abpromise for all tested applications)....
... Bovine Calf Serum; U.S. sourced, ... an uncompromising quality; Low hemoglobin; ... from animals of US origin; ... who seek an uncompromising quality. ...
...
NEWBORN CALF SERUM AND PLASMA...
Biology Products:
(Date:5/28/2015)... GLEN ALLEN, Va. , May 28, 2015 ... announced the release of a new report titled ... self-healing materials (reversible polymers, inorganic capsule and vascular ... self-healing coatings) will grow to around $2.7 billion ... latest deliverable from n-tech,s extensive coverage of smart ...
(Date:5/27/2015)... May 27, 2015   Codonics ... systems and image documentation solutions and ... technologically-advanced automation solutions, is pleased to announce ... Codonics® Safe Label System® (SLS), an award-winning ... with the Omnicell Anesthesia Workstation, helps prevent ...
(Date:5/26/2015)... , May 26, 2015 ... announced the addition of the "Saudi Arabia ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... Arabia is projected to grow at ... high growth is attributed to the surging demand ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2
... in Uganda who self-paid for their antiretroviral medications experienced ... or supply logistical disruptions. These treatment interruptions led ... patients. , These findings by a team led by ... Kampala, and UCSF are reported in the April 22, ...
... pediatric specialists at Baylor College of Medicine have discovered a ... that allows drugs to enter cancer cells. , The research ... and Biomolecular Chemistry. , All living cells defend themselves ... form a protective cocoon around the cell's inner machinery and ...
... cells to turnover their contents, something that they do ... and radiation, but it is not known if this ... survive the anti-cancer therapy. However, in a study using ... the University of Pennsylvania have now shown that autophagy ...
Cached Biology News:Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2Buckyballs used as 'passkey' into cancer cells 2
(Date:5/27/2015)... MARLBOROUGH, Mass. , May 27, 2015 /PRNewswire/ ... a biotechnology company focused on discovering and developing ... and ophthalmology, today announced that it has commenced a ... warrants to purchase shares of its common stock ... its common stock. The shares of common stock, ...
(Date:5/27/2015)... , May 27, 2015 /CNW/ - CQDM, Brain Canada ... to $8.5M to six (6) multi-disciplinary and multi-provincial research ... within their Focus on Brain strategic initiative. To this ... involved as in-kind contributions. This exciting announcement was made ... for Neuroscience in the presence of Inez Jabalpurwala, President ...
(Date:5/27/2015)... BETHESDA, Md. , May 27, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for cancer, ... Chief Technical Officer of the Company, will be making ... Annual Meeting in Chicago on ... CDT, at the Industry Expert Theater in McCormick Place. ...
(Date:5/27/2015)... 27, 2015 The Medical Innovation Impact ... of regulation on medical innovation, has been developed at ... of Fairleigh Dickinson University’s ( FDU ) Rothman Institute ... pertains to new FDA (Food & Drug Administration) ... the approval of certain medical devices. , “The ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 2Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 4Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 5Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 6Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 7Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 8Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 9Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 10NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2